Statistics
Publications
1
Citations
12
H-Index
1
Active since
2012
Affiliations
Novartis (China)(Current)
Weiyong Kong is an author at Novartis (China) specializing in impurity reactivity, chiral product synthesis, and drug discovery.
Publications per year
2012–2012
1
1
A Scalable Synthesis of a Hydroxamic Acid LpxC Inhibitor
Zhongbo Fei, Weiyong Kong, Huaimin Wang et al. · Organic Process Research & Development · 2012 · 12 citations
1–1 of 1